Tivity Health (NASDAQ:TVTY) Rating Increased to Hold at ValuEngine

Share on StockTwits

ValuEngine upgraded shares of Tivity Health (NASDAQ:TVTY) from a sell rating to a hold rating in a research note published on Tuesday, ValuEngine reports.

Other analysts have also recently issued reports about the company. Barrington Research reissued an outperform rating on shares of Tivity Health in a research note on Thursday, August 8th. Piper Jaffray Companies dropped their target price on shares of Tivity Health from $33.00 to $25.00 and set an overweight rating on the stock in a report on Thursday, August 8th. Cantor Fitzgerald set a $45.00 price target on shares of Tivity Health and gave the company a buy rating in a research note on Monday, August 26th. Zacks Investment Research cut shares of Tivity Health from a hold rating to a sell rating in a report on Friday, November 15th. Finally, Chardan Capital lowered their price objective on shares of Tivity Health from $33.00 to $24.00 and set a buy rating for the company in a research report on Friday, August 23rd. One investment analyst has rated the stock with a sell rating, one has given a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of Buy and an average target price of $31.33.

NASDAQ:TVTY opened at $22.47 on Tuesday. Tivity Health has a 1 year low of $14.84 and a 1 year high of $41.26. The company has a current ratio of 0.94, a quick ratio of 0.78 and a debt-to-equity ratio of 1.96. The stock has a market cap of $1.08 billion, a price-to-earnings ratio of 9.60, a PEG ratio of 0.99 and a beta of 1.15. The stock has a 50-day moving average price of $18.81 and a two-hundred day moving average price of $17.73.

Tivity Health (NASDAQ:TVTY) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.46 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.56 by ($0.10). The business had revenue of $303.90 million during the quarter, compared to the consensus estimate of $301.52 million. Tivity Health had a return on equity of 21.67% and a net margin of 6.41%. The firm’s revenue was up 100.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.59 earnings per share. Sell-side analysts forecast that Tivity Health will post 2.17 earnings per share for the current year.

Several hedge funds have recently bought and sold shares of TVTY. Public Employees Retirement System of Ohio grew its holdings in shares of Tivity Health by 47.4% during the second quarter. Public Employees Retirement System of Ohio now owns 2,409 shares of the company’s stock worth $40,000 after buying an additional 775 shares in the last quarter. Tower Research Capital LLC TRC raised its position in Tivity Health by 349.7% in the 3rd quarter. Tower Research Capital LLC TRC now owns 2,788 shares of the company’s stock valued at $46,000 after buying an additional 2,168 shares during the last quarter. Resources Investment Advisors LLC. bought a new stake in Tivity Health in the 2nd quarter valued at approximately $61,000. Meadow Creek Investment Management LLC lifted its stake in Tivity Health by 22.8% in the 2nd quarter. Meadow Creek Investment Management LLC now owns 4,912 shares of the company’s stock valued at $81,000 after acquiring an additional 912 shares in the last quarter. Finally, Delta Asset Management LLC TN boosted its position in Tivity Health by 1,851.9% during the 2nd quarter. Delta Asset Management LLC TN now owns 5,270 shares of the company’s stock worth $87,000 after acquiring an additional 5,000 shares during the last quarter.

Tivity Health Company Profile

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.

Recommended Story: Is it better to buy a fund with a higher or lower NAV?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.